Literature DB >> 10901721

Cutaneous malakoplakia: a report of two cases with the use of anti-BCG for the detection for micro-organisms.

D R Mehregan1, A H Mehregan, D A Mehregan.   

Abstract

Malakoplakia is an uncommon granulomatous infectious disease that is found primarily in the genito-urinary tract, but may rarely involve the skin. Histologic findings are marked by the presence of foamy macrophages containing basophilic concentric spherules, the Michaelis-Gutman bodies. Micro-organisms are not readily identifiable. Immunostaining with polyclonal anti-mycobacterium bovis (BCG) has been described as a method of identifying bacterial and fungal organisms in situations where organisms may be sparse. We report 2 cases of cutaneous malakoplakia with demonstration of organisms by immunostaining with anti-BCG antibodies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10901721     DOI: 10.1067/mjd.2000.100538

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Cutaneous malakoplakia presenting as a groin swelling and graft failure.

Authors:  Ross Andrew Macdonald; Colin Moyes; Marc Clancy; Peter Douglas
Journal:  BMJ Case Rep       Date:  2019-04-23

2.  Cutaneous malakoplakia masquerading as pyoderma gangrenosum.

Authors:  Mariam Smith-Pliego; Jose Contreras-Ruiz; Siobhan Ryan; R Gary Sibbald; Wedad Hanna; Rodrigo Roldan-Marin
Journal:  Int Wound J       Date:  2016-08-15       Impact factor: 3.315

Review 3.  Cutaneous malakoplakia: case report and review.

Authors:  João Paulo Junqueira Magalhães Afonso; Patricia Naomi Ando; Maria Helena Valle de Queiroz Padilha; Nilceo Schwery Michalany; Adriana Maria Porro
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

4.  Perianal cutaneous malakoplakia in an allogeneic stem cell transplant recipient.

Authors:  Yen Chen Kevin Ko; Alina Markova; Christina Cho; Mini Kamboj; Klaus J Busam; Cecilia Lezcano
Journal:  J Cutan Pathol       Date:  2021-01-20       Impact factor: 1.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.